PS

PharmaSGP Holding SEXETRA PharmaSGP Holding Stock Report

Last reporting period 31 Mar, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.461

Micro

Exchange

XETR - Xetra

PSG.DE Stock Analysis

PS

Uncovered

PharmaSGP Holding SE is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

87/100

Moderate score

Market cap $B

0.461

Dividend yield

8.04 %

Shares outstanding

12 B

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

View Section: Eyestock Rating